Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imaging.
<h4>Objectives</h4>Metabolic changes in the substantia nigra of patients with Parkinson's disease were previously investigated in different molecular-pathological examinations. The aim of our study was the in vivo measurement of these alterations using three-dimensional magnetic res...
Guardado en:
Autores principales: | Adriane Gröger, Rupert Kolb, Rita Schäfer, Uwe Klose |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a8ed90ca6314fb193729682521030a2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
por: Christian Dölle, et al.
Publicado: (2016) -
Paraquat Toxicogenetics: Strain-Related Reduction of Tyrosine Hydroxylase Staining in Substantia Nigra in Mice
por: Carolina Torres-Rojas, et al.
Publicado: (2021) -
Automated Assessment of the Substantia Nigra Pars Compacta in Parkinson’s Disease: A Diffusion Tensor Imaging Study
por: Niels Bergsland, et al.
Publicado: (2021) -
Genetic and constitutional factors are major contributors to substantia nigra hyperechogenicity
por: Juan F. Vázquez-Costa, et al.
Publicado: (2017) -
Stability of AI-Enabled Diagnosis of Parkinson’s Disease: A Study Targeting Substantia Nigra in Quantitative Susceptibility Mapping Imaging
por: Bin Xiao, et al.
Publicado: (2021)